NCT00116324 Predicting the Response to Montelukast by Genetic Variation in Asthmatics Status COMPLETED Phase PHASE3
NCT00116129 Efficacy and Safety of an Oral Growth Hormone Drug in the Treatment of Fibromyalgia Status COMPLETED Phase PHASE2
NCT00112437 A Study to Examine the Effects of an Experimental Drug on Postmenopausal Osteoporosis (MK-0822-004) Status COMPLETED Phase PHASE2
NCT00112372 Study of Oral Ridaforolimus (AP23573, MK-8669) to Treat Patients With Refractory or Advanced Malignancies (MK-8669-016 AM4)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00111891 An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia (0524A-032) Status COMPLETED Phase PHASE2
NCT00111813 Phase 1 Study of Vorinostat and Bortezomib in Multiple Myeloma (MK-0683-015 EXT 1 (AM1)) Status COMPLETED Phase PHASE1
NCT00110188 Ridaforolimus (AP23573/MK-8669) in Participants With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)(MK-8669-017) Status COMPLETED Phase PHASE2
NCT00109538 Study of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978AM3)(TERMINATED) Status TERMINATED Phase PHASE3
NCT00109343 V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019) Status COMPLETED Phase PHASE3
NCT00109278 A Measles, Mumps, and Rubella Investigational Vaccine Trial (V205C-010)(COMPLETED) Status COMPLETED Phase PHASE2
NCT00109148 An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006) Status COMPLETED Phase PHASE2
NCT00109135 A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers (0364-007) Status COMPLETED Phase PHASE2
NCT00109122 Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007) Status COMPLETED Phase PHASE2
NCT00109109 A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Multiple Myeloma (0683-004) Status TERMINATED Phase PHASE1
NCT00108017 Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00106808 Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00106704 Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035) Status COMPLETED Phase PHASE3